Obstetrics & Gyn

Pregnancy complications: The hidden PAD risk factor you're missing?

Pregnancy complications like pre-eclampsia and gestational diabetes may increase a woman's long-term risk of developing peripheral artery disease. Clinicians should consider these obstetric histories when assessing cardiovascular risk.

Perimenopause: Why your diagnostic toolkit needs an upgrade

A new clinical toolkit offers structured guidance for managing perimenopause in primary care, addressing symptoms and improving diagnostic clarity.

Male Contraception: Why are options so limited, and what's next?

The World Health Organization has published target product profiles for male contraceptive methods, detailing the efficacy, safety, and user attributes required for future development.

Oral hormone therapy: Is its VTE risk still underestimated?

Oral hormone therapy, including combined oral contraceptives and menopausal hormone therapy, significantly increases venous thromboembolism risk. Clinicians must weigh these risks against therapeutic benefits.

Early menopause: A hidden driver of hypertension risk?

Women experiencing menopause at a younger age face an elevated risk of developing hypertension, according to observational data.

Lead in tampons: Is there a hidden risk for your patients?

Recent reports of lead detection in tampons have raised concerns, but current data indicates no established safety signals for patients.

Menopausal Hormone Therapy: A Cost-Effective Path to Better Health?

Menopausal hormone therapy may offer significant health benefits while simultaneously reducing healthcare costs, challenging some long-held perceptions about its value.

Perimenopause and chest pain: When to suspect cardiac causes

Chest symptoms in perimenopausal women often mimic cardiac events, complicating diagnosis. Clinicians must differentiate benign presentations from urgent cardiovascular concerns.

Europe's Cervical Cancer Elimination Targets: A Reality Check

Most European countries lack the robust screening registries needed to meet WHO cervical cancer elimination targets, hindering progress despite HPV testing and vaccination efforts.